1-3 of 3
Marsha Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Azra Raza, MD, Naomi Galili, Ph.D., Scott Smith, MD, PhD, FACP, John E. Godwin, MD, MS, Ralph Boccia, MD, Han Myint, MD, Daruka Mahadevan, MD, PhD, Deborah Mulford, MD, Mark Rarick, MD, Mary Ann Allison, MD, Ostap Melnyk, MD, Lisa Meng, Marsha Jones, MD, Gail Brown, MD, Shelby A Young, RN, BSN, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2010) 116 (21): 2910.
https://doi.org/10.1182/blood.V116.21.2910.2910
Published: 2010
Journal Articles

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome

Clinical Trials & Observations
Azra Raza, Naomi Galili, Scott Smith, John Godwin, Jeffrey Lancet, Magda Melchert, Marsha Jones, James G. Keck, Lisa Meng, Gail L. Brown, Alan List
Journal: Blood
Blood (2009) 113 (26): 6533–6540.
https://doi.org/10.1182/blood-2009-01-176032
Published: 2009
Journal Articles

Phase 1 Dose Escalation Study of TLK199 Tablets (Telintra), a Novel Glutathione Analog, in Myelodysplastic Syndrome.

Azra Raza, MD, Magda Melcert, MD, Naomi Galili, PhD, Scott E. Smith, MD, PhD, FACP, John E. Godwin, MD, MS, Shelby Young, RN, Lisa Meng, MS, Marsha Jones, MD, Gail L. Brown, MD, Jeffery Lancet, MD, Alan List, MD
Journal: Blood
Blood (2007) 110 (11): 1454.
https://doi.org/10.1182/blood.V110.11.1454.1454
Published: 2007